Erectus solution articularly Annex 24 mg. 2 ml
Sodium salt of hyaluronic acid is naturally present polysaccharide consisting of a sequence of disaccharide units of sodium gluconate and N-Acetylglucosamine
Erectus solution articularly Annex 24 mg. / 2 ml
ERECTUS is a sterile, non-pyrogenic, viscoelastic solution of sodium salt of hyaluronic acid produced by fermentation.
Sodium salt of hyaluronic acid is naturally present polysaccharide consisting of a sequence of disaccharide units of sodium gluconate and N-Acetylglucosamine.
Hyaluronic acid is present in synovial fluid and various human tissues such. cartilage. It is secreted continuously in joint space and is a major component of synovial fluid, which gives the characteristic viscosity and elasticity.
These properties are essential for lubricating and shock-absorbing function of the liquid in normal joints to protect the cartilage and soft tissue mechanical stress and injury.
Injury or degenerative joint diseases lead to qualitative and quantitative deficiency of hyaluronic acid, followed by reduction of viscosity, as already documented.
Consequently, failure to appear lubrication and shock-absorbing functions, resulting in loss of joint function and pain.
Numerous reports in the literature suggest that intra-articular injection of hyaluronic acid can restore the viscoelastic properties of synovial fluid to relieve pain and improve joint mobility.
One ERECTUS filled syringe containing 2 ml 1.2%-solution of the sodium salt of hyaluronic acid, sodium chloride, disodium hydrogen phosphate dodecahydrate, sodium phosphate dihydrate divodoroden, water for injection.
Erectus (ERECTUS) is viscoelastic supplement for synovial fluid. ERECTUS acts as a lubricant and mechanical support of the knee. It is indicated for the treatment of patients with osteoarthritis of the knee.
Dosage and administration
ERECTUS is injected into the affected joint once a week, 3 to 5 times. Both can be treated several joints. It is a repetition of the treatment.
The product should only be placed by a doctor qualified to make intra-articular injections.
All rules regarding proper asepsis and method of injection should be strictly adhered to. Stavnen effusion (the end), if any, should be removed before it is injected ERECTUS.
It is only in the joint space with a suitable sterile needle (eg 18G or 20G).
Do not put patients with known / suspected hypersensitivity to any component of the product. ERECTUS should not be injected in patients with infections or skin diseases around the injection site. Do not place in the inflamed joints, such as rheumatoid arthritis or spondylitis disease.
Warnings and Precautions
Although preclinical studies in animals indicate that the product has no potential reproductive and developmental toxicity, ERECTUS ® has not been studied in pregnant women.
Do not use if package is damaged.
Do not use after the expiry date stated on the package. The expiry date refers to the product stored in original packaging at a temperature not exceeding 25 ° C.
The contents of the prefilled syringe is sterile. The syringe is packaged in a hermetically sealed blister.
ERECTUS is a single use, discard the syringe after injection according to applicable local regulations.
Keep away from children.
After the injection is recommended not to wear weights for 1-2 days.
Local pain, swelling, warmth and redness may occur occasionally at the injection site. These symptoms are usually mild and transient. Rare more pronounced inflammatory reactions such as effusion and / or infection after an intraarticular injection of hyaluronic acid and rare anaphylactic reactions.
As with any intraarticular therapy may appear septic arthritis, but it happens very rarely, if they meet the general aseptic procedures for injection.
Do not use concomitantly with disinfectants containing quaternary ammonium salts such as hyaluronic acid and precipitate in their presence.
To avoid possible interactions to avoid concomitant use of ERECTUS ® with other intraarticular products. .
Store at temperatures up to 25 ° C.
One pre-filled syringe contains ERECTUS ® 24 mg / 2 ml sodium salt of hyaluronic acid, a moist heat sterilized.